Call for Chapters: Genomics-Driven Drug Discovery Through Pharmacogenomics

Editors

Arli Parikesit, Indonesia International Institute for Life Sciences, Indonesia
Mehrdad Naderi, , Latvia
Anupam Singh, Bansal Institute of Engineering and Technology, India
RAJESH KONNUR, Eudoxia Research Centre, India
Saptarshi Mukherjee, GoldSmith Institute of Advanced Research [GIAR], India

Call for Chapters

Proposals Submission Deadline: July 1, 2024
Full Chapters Due: August 5, 2024

Introduction

In this groundbreaking book, we embark on a transformative journey into the future of personalized medicine. This comprehensive guide illuminates the path from genomic data to patient-tailored therapies, highlighting the revolutionary impact of pharmacogenomics in drug development. Readers will discover the intricate processes of identifying genomic markers, the challenges of integrating genomics into drug discovery, and the potential to enhance efficacy and safety in therapeutics. Through expert insights and real-world examples, this book proposes a new paradigm where genomics and medicine converge to optimize patient care and herald a new era of drug discovery.

Objective

The objective of this book is to explore the transformative impact of genomics and pharmacogenomics in the field of drug discovery and development. This book aims to provide a comprehensive overview of how genetic information is revolutionizing the identification of drug response markers and the personalization of medicine. It will delve into the technological advancements that enable this shift, such as high-throughput sequencing and gene expression analysis, and discuss the implications for clinical research and medicine. The book will also address the ethical considerations and the interdisciplinary approach required to harness the full potential of genomics in drug discovery. Furthermore, it will serve as a valuable resource for professionals in the fields of genomics, pharmaceuticals, and personalized medicine, offering insights into the future of genotype-driven therapy decisions and the optimization of patient care.

Target Audience

The target audience for this book would likely be professionals and researchers in the fields of genomics, pharmacology, and personalized medicine. This includes geneticists, pharmacologists, bioinformaticians, and medical scientists who are involved in drug development and interested in how genetic variations influence drug responses. Additionally, healthcare providers who aim to integrate pharmacogenomics into clinical practice would find this book valuable. Academics and students in biomedical sciences could also benefit from the detailed exploration of genomics in drug discovery. Furthermore, pharmaceutical industry professionals, including those in R&D and regulatory affairs, would gain insights into the applications of pharmacogenomics in drug development and personalized therapy strategies.

Recommended Topics

Future perspectives and challenges of genomics driven drug discovery Ethical Legal and Social Implications of Genomics Driven Drug Discovery Emergence of Pharmacogenomics in the Era of Personalized Medicine: A Paradigm Shift Advanced High-Throughput Screening Platforms in Drug discovery Precision Medicine and Genomic Biomarker Discovery Omics Integration and Network Analysis for Systems Medicine Pharmacogenomics in the Era of Personalized Medicine Drug Repurposing And Mendelian Randomization Precision Medicine And Genomic Biomarker Discovery Advanced High-Throughput Screening Platforms in Drug Discovery Data Quality and Reproducibility in Drug Discovery Global Collaborations and Data Sources in Genomics Research in Drug Discovery Ethical, Legal and Social Implications of Genomics Driven Drug Discovery Future Perspectives and Challenges of Genomics Driven Drug Discovery

Submission Procedure

Researchers and practitioners are invited to submit on or before July 1, 2024, a chapter proposal of 1,000 to 2,000 words clearly explaining the mission and concerns of his or her proposed chapter. Authors will be notified by July 22, 2024 about the status of their proposals and sent chapter guidelines. Full chapters are expected to be submitted by August, 2024, and all interested authors must consult the guidelines for manuscript submissions at https://www.igi-global.com/publish/contributor-resources/before-you-write/ prior to submission. All submitted chapters will be reviewed on a double-blind review basis. Contributors may also be requested to serve as reviewers for this project.

Note: There are no submission or acceptance fees for manuscripts submitted to this book publication, Genomics-Driven Drug Discovery Through Pharmacogenomics. All manuscripts are accepted based on a double-blind peer review editorial process.

All proposals should be submitted through the eEditorial Discovery® online submission manager.



Publisher

This book is scheduled to be published by IGI Global (formerly Idea Group Inc.), an international academic publisher of the "Information Science Reference" (formerly Idea Group Reference), "Medical Information Science Reference," "Business Science Reference," and "Engineering Science Reference" imprints. IGI Global specializes in publishing reference books, scholarly journals, and electronic databases featuring academic research on a variety of innovative topic areas including, but not limited to, education, social science, medicine and healthcare, business and management, information science and technology, engineering, public administration, library and information science, media and communication studies, and environmental science. For additional information regarding the publisher, please visit https://www.igi-global.com. This publication is anticipated to be released in 2025.



Important Dates

July 1, 2024: Proposal Submission Deadline
July 22, 2024: Notification of Acceptance
August 5, 2024: Full Chapter Submission
September 1, 2024: Review Results Returned
October 13, 2024: Final Acceptance Notification
October 27, 2024: Final Chapter Submission



Inquiries

Arli Parikesit
Indonesia International Institute for Life Sciences
arli.parikesit@i3l.ac.id

Mehrdad Naderi

mehrdad-naderi@hotmail.com

Anupam Singh
Bansal Institute of Engineering and Technology
anupam4uk@gmail.com

RAJESH KONNUR
Eudoxia Research Centre
rajesh.konnur@gmail.com

Saptarshi Mukherjee
GoldSmith Institute of Advanced Research [GIAR]
saptarshi5k17@gmail.com



Classifications


Computer Science and Information Technology; Medical, Healthcare, and Life Sciences; Science and Engineering
Back to Call for Papers List